Ling Wang


BTIG Analyst Bullish on Ocular Therapeutix Inc (OCUL) Following Strategic Collaboration with Regeneron

Ocular Therapeutix Inc (NASDAQ:OCUL) shares popped nearly 14% yesterday, after the biopharmaceutical company announced a $10 million drug development deal with Regeneron Pharmaceuticals Inc (NASDAQ:REGN) …

BTIG Remains Sidelined on Merrimack Pharmaceuticals Inc (MACK) Despite Encouraging ONIVYDE Script Data for August

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) shares shot up nearly 21% yesterday on back of August’s strong script data for ONIVYDE, the first approved anti-cancer treatment, …

BTIG Remains Sidelined on Merrimack Pharmaceuticals Inc (MACK) on Back of Cash Concerns

Merrimack Pharmaceuticals Inc’s (NASDAQ:MACK) leading pipeline drug, ONIVYDE, an irinotecan liposome injection designed to treat patients suffering from metastatic pancreatic cancer, recently underperformed …

Oppenheimer Weighs in On Geron Corporation (GERN) Following ET and MF Study Publications

In a research report issued today, Oppenheimer’s healthcare analyst Ling Wang reiterated an Outperform rating on shares of Geron Corporation (NASDAQ:GERN) with a $5.50 …

Oppenheimer Reiterates Outperform on Rockwell Medical Inc (RMTI) Following Positive Feedback on Triferic

In a research report released on Friday, Oppenheimer analyst Ling Wang reiterated an Outperform rating on shares of Rockwell Medical Inc (NASDAQ:RMTI) with a …

Rockwell Medical Inc Shares On The Rise Amid Earnings; Oppenheimer Reiterates Outperfom

Rockwell Medical Inc (NASDAQ:RMTI) shares have popped 13.24% to $15.

Oppenheimer Offers Commentary on Rockwell Medical Inc ׁ(RMTI) Following Meeting with Management

Oppenheimer analyst Ling Wang weighed in today with a few insights on Rockwell Medical Inc (NASDAQ:RMTI), after having a meeting with CEO Robert Chioini and …

Oppenheimer Maintains Outperform on Rockwell Medical Inc Ahead of Triferic Launch

Oppenheimer analyst Ling Wang weighed in with a favorable report on shares of Rockwell Medical Inc (NASDAQ:RMTI), as the company plans to launch Triferic, a …

Agios Pharmaceuticals Inc’s Shares are Fully Valued at Current Levels: Oppenheimer

In a research report released April 20, Oppenheimer analyst Ling Wang initiated coverage on shares of Agios Pharmaceuticals Inc (NASDAQ:AGIO), while no price target was …

Oppenheimer Initiates Outperform on La Jolla Pharmaceutical Company; Sees 125% Upside for the Stock

In a research report published April 20, Oppenheimer analyst Ling Wang initiated coverage on shares of La Jolla Pharmaceutical Company (NASDAQ:LJPC) with an Outperform …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts